Management of Stage 2 Hypertension

Classification and Risk Assessment

A blood pressure of 147/76 mmHg is classified as stage 2 hypertension according to the 2017 ACC/AHA guidelines and the 2020 International Society of Hypertension guidelines, which significantly increases cardiovascular risk 1, 2
The American College of Cardiology and the American Heart Association classify a BP of 147/76 mmHg as stage 2 hypertension, requiring immediate intervention 1, 2

The American College of Cardiology recommends immediate initiation of drug treatment along with lifestyle interventions for stage 2 hypertension, with a goal to reduce BP by at least 20/10 mmHg 1, 4
The International Society of Hypertension guidelines recommend starting drug treatment immediately for BP ≥140/90 mmHg, particularly in high-risk patients, with first-line agents including thiazide diuretics, ACE inhibitors, ARBs, and calcium channel blockers 1, 4

The American Heart Association recommends implementing lifestyle modifications concurrently with pharmacological therapy, including weight loss if overweight/obese, adopting a DASH eating pattern, reducing sodium intake to <2,300 mg/day, increasing physical activity, and limiting alcohol consumption 1, 3

The American College of Cardiology and the American Heart Association recommend a target BP of <130/80 mmHg, with a goal to reduce BP by at least 20/10 mmHg, and to reassess BP within 1 month after initiating therapy 1, 2, 5
The International Society of Hypertension guidelines recommend achieving target BP within 3 months, and adjusting medication doses or adding additional agents if necessary 1, 3

The European Society of Cardiology recommends considering secondary causes of hypertension when BP is difficult to control, and accounting for white-coat hypertension or masked hypertension, with expected BP reduction with standard doses of first-line agents being approximately 9/5 mmHg 6, 7
Combination therapy can lower office BP by up to 20/11 mmHg, according to the European Heart Journal 6

Therapeutic inertia is a major cause of poor BP control, according to the European Heart Journal, and inadequate dosing or inappropriate drug combinations can lead to treatment failure 4, 6
Failing to address medication adherence is a common cause of uncontrolled hypertension, according to the American College of Cardiology 1